Meditation and Yogic Breathing-driven Modulation of Neurofluid Coupling and Brain Clearance (SPANDHA)
This study will examine whether meditation and yogic breathing can alter brain fluid movement and waste clearance in healthy adults. It will also evaluate the GLYMPHOMETER, a new external forehead-worn device designed to objectively measure changes in brain fluid movement and exchange during meditation.
研究概览
详细说明
The glymphatic system is a brain waste-clearance pathway that facilitates the movement of cerebrospinal fluid (CSF) and interstitial fluid and is thought to play an important role in maintaining brain homeostasis. Emerging evidence suggests that respiration, autonomic activity, and changes in cerebral blood flow may influence CSF dynamics and related neurofluid processes. However, the effects of voluntary breathing practices and meditation on these physiological mechanisms in humans remain incompletely understood.
The SPANDHA study will investigate whether structured yogic breathing (Pranayama; specifically Nadi Shuddhi) and/or meditation (Shoonya meditation) are associated with changes in neurofluid dynamics and related physiological measures. The study will use the GLYMPHOMETER, a forehead-mounted multimodal device designed to measure physiological signals associated with neurofluid coupling during naturalistic meditation and breathing practices. The system incorporates multi-wavelength electroencephalography (EEG) and near-infrared spectroscopy (NIRS) to characterize changes in cerebral electrical activity, cerebral hemodynamics, and neurofluid-related dynamics while participants engage in the interventions.
The study will enroll approximately 100 participants, including 50 novice and 50 experienced practitioners. Using a 2-sequence crossover, participants will complete two study visits involving meditation and yogic breathing conditions. The study will evaluate changes in measures of neurofluid dynamics, cerebral compliance, autonomic regulation including heart-rate variability (HRV), and EEG-derived brain states associated with the interventions. Participants will be stratified by experience level (novice/advance) and randomized within each stratum to one of the two intervention sequences.
A subset of participants will undergo additional validation assessments using phase-contrast magnetic resonance imaging (MRI) and blood-based biomarkers. These assessments will be used to examine the relationship between measurements obtained with the GLYMPHOMETER and established measures of CSF and cerebrovascular physiology.
The primary objective of the study is to characterize the acute physiological effects of meditation and yogic breathing on neurofluid dynamics and related brain and autonomic measures. The findings may provide preliminary evidence regarding the feasibility of using voluntary breathing and meditation practices to modulate physiological processes associated with glymphatic function and may inform future studies of non-pharmacological approaches to brain health.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Balachundhar Subramaniam, MD MPH
- 电话号码:(781) 472-0572
- 邮箱:bsubrama@bidmc.harvard.edu
学习地点
-
-
Massachusetts
-
Boston、Massachusetts、美国、02215
- BIDMC
-
接触:
- Deepthi R Johal, PhD
- 电话号码:8574263244
- 邮箱:drajashe@bidmc.harvard.edu
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Healthy adults, 25-60 years old.
- Novice or Advanced as defined above.
- Fluent in English.
- Able to travel to BIDMC site for two days approximately 3-7 days apart.
Exclusion Criteria:
- History of neurological and/or neurodegenerative disorders (e.g., epilepsy, stroke, mild cognitive impairment, dementia)
- History of cardiovascular and respiratory illnesses
- History of major psychiatric disorders (e.g., schizophrenia, bipolar disorder)
- Currently diagnosed mental health issues (e.g., anxiety, depression)
- Current use of psychoactive medications, including medications prescribed for anxiety, depression, or other psychiatric conditions, or current use of stimulants or other medications that may substantially affect central nervous system function or study outcomes.
- Skin ailments, abrasions or contusions, particularly located on the forehead and face
学习计划
研究是如何设计的?
设计细节
- 主要用途:其他
- 分配:非随机化
- 介入模型:交叉作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:Novice Meditators
Less than 1 year of consistent meditation practice. |
Nadi Shuddhi is a structured yogic breathing practice involving slow, alternating respiration through the left and right nostrils in a prescribed sequence. Shoonya meditation is a structured contemplative practice characterized by conscious non-doing, in which participants maintain a relaxed, alert state while minimizing deliberate attentional selection, cognitive elaboration, and engagement with internal or external stimuli. |
|
有源比较器:Advanced Meditators
More than 5 years or a minimum of 2500 hours of consistent meditation practice |
Nadi Shuddhi is a structured yogic breathing practice involving slow, alternating respiration through the left and right nostrils in a prescribed sequence. Shoonya meditation is a structured contemplative practice characterized by conscious non-doing, in which participants maintain a relaxed, alert state while minimizing deliberate attentional selection, cognitive elaboration, and engagement with internal or external stimuli. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Acquisition of physiological data using the GLYMPHOMETER during meditation and yogic breathing sessions.
大体时间:At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2
|
Participants meeting threshold for analyzable device recordings. |
At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Neurofluid-related physiological measures during Shoonya meditation and Nadi Shuddhi breathing.
大体时间:At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2
|
Changes in GLYMPHOMETER-derived measures of neurofluid coupling, during Shoonya meditation and Nadi Shuddhi breathing. (Measurement device: Glymphometer; Measure: Neurofluid coupling aka Fluid dynamics in brain) |
At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2
|
|
Autonomic regulation during Shoonya meditation and Nadi Shuddhi breathing.
大体时间:At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2
|
Changes in heart-rate variability (HRV) during Shoonya meditation and Nadi Shuddhi breathing. |
At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2
|
|
Very-low-frequency physiological signal characteristics
大体时间:At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2
|
Changes in predefined very-low-frequency (0.001-0.1 Hz) signal characteristics derived from GLYMPHOMETER medical™ recordings and their relationship to neurofluid-related measures. |
At each study visit while the meditation is being practiced. Expected acquisition window: 20 minutes; Total number of visits: 2
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Differences in neurophysiological responses according to meditation experience.
大体时间:From date of enrollment until end of both study visits; assessed up to 4 weeks from enrollment.
|
Comparison of changes in GLYMPHOMETER-derived measures of neurofluid coupling between novice and advanced meditators. |
From date of enrollment until end of both study visits; assessed up to 4 weeks from enrollment.
|
|
Mindful Attention Awareness Scale
大体时间:Once at Baseline. Estimated acquisition window: 5-8 minutes
|
We assess for change in Mindfulness levels by using a validated scale for this purpose namely, Mindfulness Attention Awareness Scale (MAAS). The scale measures the individuals' ability for receptive awareness and attention to present. This aids in evaluating any change on the individual's awareness levels after the Inner engineering intervention. We compute the MAAS scores for each participant which is a mean score for 15 item questionnaires and compare the pre & post intervention results to look for change. Participants are asked to rate on a scale of 1 (Almost Always) to 6 (Almost Never) to assess the frequency of occurrence of each experience. Mean is then computed using items from each of the 15 questions to create a MAAS score, ranging from 0 to 6. Higher MAAS scores indicate better mindfulness state. |
Once at Baseline. Estimated acquisition window: 5-8 minutes
|
|
Meditation Depth Questionnaires
大体时间:At each study visit after the meditation practice is completed. Expected acquisition window: 10-15 minutes; Total number of visits: 2
|
This 30-item measure assesses the subjective depth of meditation across progressively deeper experiential states. Items are typically rated on a 5-point Likert scale and are grouped into five empirically derived domains: hindrances, relaxation, personal-self/concentration, essential/transpersonal qualities, and transpersonal-self/non-duality. Together, these domains capture experiences ranging from obstacles and relaxation during meditation to focused concentration, transpersonal qualities, and experiences of diminished self-boundaries or non-dual awareness. |
At each study visit after the meditation practice is completed. Expected acquisition window: 10-15 minutes; Total number of visits: 2
|
|
Correlation between GLYMPHOMETER-derived neurofluid metrics and MRI-based neurofluid dynamics (Validation of Portable Device).
大体时间:From date of enrollment until end of both study visits; assessed up to 4 weeks from enrollment.
|
This outcome evaluates the concurrent validity of the portable device against the gold standard. The statistical method will be a correlation analysis (Pearson or Spearman, as appropriate based on data distribution).
|
From date of enrollment until end of both study visits; assessed up to 4 weeks from enrollment.
|
|
Correlation between GLYMPHOMETER-derived neurofluid metrics and plasma brain-derived biomarkers.
大体时间:From date of enrollment until end of both study visits; assessed up to 4 weeks from enrollment.
|
This outcome evaluates the relationship between neurofluid dynamics and blood-based markers of brain clearance. The statistical method will be a correlation analysis (Pearson or Spearman).
|
From date of enrollment until end of both study visits; assessed up to 4 weeks from enrollment.
|
|
Qualitative assessment of meditation and breathing experiences.
大体时间:At each study visit after the meditation practice is completed. Expected acquisition window: 30 minutes; Total number of visits: 2
|
Qualitative characterization of participant experiences using one-on-one micro-phenomenological interviews. |
At each study visit after the meditation practice is completed. Expected acquisition window: 30 minutes; Total number of visits: 2
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 2026P000655
- GRT69415 (其他赠款/资助编号:Inner Science Research Foundation)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.